A detailed history of Aventura Private Wealth, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Aventura Private Wealth, LLC holds 9 shares of MRNA stock, worth $222. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9
Holding current value
$222
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 07, 2026

BUY
$23.56 - $28.49 $212 - $256
9 New
9 $265,000
Q2 2025

Jan 07, 2026

SELL
$23.65 - $28.54 $118 - $142
-5 Reduced 35.71%
9 $248,000
Q1 2025

Jan 07, 2026

BUY
$28.35 - $47.53 $141 - $237
5 Added 55.56%
14 $397,000
Q4 2024

Jan 07, 2026

BUY
$36.85 - $63.93 $221 - $383
6 Added 66.67%
15 $624,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Aventura Private Wealth, LLC Portfolio

Follow Aventura Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aventura Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aventura Private Wealth, LLC with notifications on news.